UroMems
Developing an active implantable medical device which compensates for sphincter insufficiency.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 Valuation: €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | €44.0m | Series C | |
| Total Funding | 000k | ||
| EUR | 2016 | 2017 | 2018 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
UroMems is a pioneering startup that is revolutionizing the medical industry with its innovative technology. The company specializes in developing smart, active implantable medical devices designed to treat stress urinary incontinence (SUI), a condition that affects both men and women. SUI can significantly impact a person's quality of life, and UroMems' technology aims to provide an efficient and personalized solution to this problem.
The company's flagship product, UroActive™, is a testament to its commitment to leveraging the latest technological advancements in embedded systems and micro-technologies. This product is designed to automatically adjust to each patient's unique needs, providing an improved experience and a better quality of life.
UroMems operates in the global medical device market, serving a broad range of clients, including hospitals, clinics, and healthcare providers. The company's business model revolves around the development, production, and sale of its innovative medical devices. The revenue is generated from the sales of these devices to healthcare providers who then offer the treatment to their patients.
Founded in 2011 by a team of experts with multiple patents to their name, UroMems has positioned itself as a leader in the development of smart implantable medical devices. The company's groundbreaking technology and commitment to improving patient outcomes underscore its potential for growth in the medical device industry.
Keywords: UroMems, Stress Urinary Incontinence, Medical Devices, Implantable Devices, UroActive™, Healthcare, Embedded Systems, Micro-Technologies, Quality of Life, Personalized Treatment.